Health Catalyst's (HCAT) Still a 'Superior Technology Platform' - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $4.00 price target on Health Catalyst Inc. (NASDAQ: HCAT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
